Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines
Abstract Among the emerging strategies for cancer theranostics, nanomedicines offer significant promise in advancing both patients’ diagnosis and treatment. In combination with nanobodies, nanomedicines can potentially enhance the precision and efficiency of drug or imaging agent delivery, addressin...
Saved in:
| Main Authors: | Liudmyla Maksymova, Yannick A. Pilger, Lutz Nuhn, Jo A. Van Ginderachter |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Molecular Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-025-02270-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanobodies: From Discovery to AI-Driven Design
by: Haoran Zhu, et al.
Published: (2025-05-01) -
Modulating ion channels with nanobodies
by: Sher Ali, et al.
Published: (2025-06-01) -
Metal‐Coordinated NIR‐II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming
by: Yeneng Dai, et al.
Published: (2024-09-01) -
Nanobody‐mediated complement activation to kill HIV‐infected cells
by: Maria Lange Pedersen, et al.
Published: (2023-02-01) -
Enhancing substrate specificity of microbial transglutaminase for precise nanobody labeling
by: Xinglong Wang, et al.
Published: (2025-03-01)